Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer.
A group of researchers investigated if detection of circulating tumor DNA (ctDNA) after resection of colorectal cancer (CRC) identifies the patients with the highest risk of relapse, and furthermore, whether longitudinal ctDNA analysis allows early detection of relapse and informs about response to intervention. During this longitudinal cohort study massively parallel sequencing (NGS) was used […]